摘要
目的:探讨食管、贲门癌术后胃食管反流病的治疗方法。方法:将本院收治的96例食管癌、贲门癌术后胃食管反流病患者随机分成两组,治疗组给予埃索美拉唑+康复新液进行治疗,对照组给予埃索美拉唑治疗,观察两组的疗效和复发情况。结果:应用埃索美拉唑+康复新液的患者总有效率高于应用埃索美拉唑的患者,差异有统计学意义(P<0.05)。应用埃索美拉唑+康复新液的患者1年后的复发率低于应用埃索美拉唑的患者,但差异无统计学意义(P>0.05)。结论:埃索美拉唑+康复新液在治疗食管、贲门癌术后胃食管反流病方面的临床有效率高于单用埃索美拉唑,两种治疗方法的复发情况没有差别。
Objective： To study an effective treatment of gastroesophageal reflux disease after esophageal and eardia cancer operation.Method： 96 patients with gastroesophageal reflux disease after esophageal and eardia cancer operation treated by our hospital were randomly assigned into two groups. Treatment group was treated by Esomeprazole plus Kangfuxin Liquid.Matched group was treated by Esomeprazole.Then the curative effect and relapse of two groups were observed.Result： The total effective rate of the patients with Esomeprazole plus Kangfuxin Liquid was higher than those patients with Esomeprazole.The differences were significant between the two groups （ P〈0.05 ） .The relapse rate of the patients with Esomeprasole plus Kangfuxin Liquid one year later was lower than those patients with Esomeprazole.But there were no significant differences （P〉0.05） .Conclusion： The effective rate of clinical treating Gastroesophageal reflux disease after esophageal and cardia cancer operation with Esomeprazole plus Kangfuxin Liquid is higher than thatonly with Esomeprazole. There is no differences in relapse between the two treatments.
出处
《中国医学创新》
CAS
2013年第29期10-12,共3页
Medical Innovation of China
关键词
胃食管反流病
食管癌
贲门癌术后
埃索美拉唑
康复新液
疗效
Gastroesophageal reflux disease
After esophageal and cardia cancer operation
Esomeprazote
Kangfuxin Liquid
Curative effect
